Feedback / Questions
etrolizumab (RG7413) - Roche
Etrolizumab: Data from P3 HIBISCUS 1 trial (NCT02163759) for ulcerative colitis in 2020
(Roche)
-
Sep 17, 2019 -
Pharma Day 2019: Data from P3 HIBISCUS 2 trial (NCT02171429) for TNF naive ulcerative colitis in 2020
P3 data
https://www.roche.com/investors/agenda/roche-pharma-day-2019.htm
Sep 17, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious